BRONX 12 MCG + 400 MCG CAP DURA PO INAL CT FR PLAS OPC X 15
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1057304980136 -
GGREM
552923050160103 -
Código de barras
7896658048760
O que a fonte publica
- Detentor do registro
- ACHÉ LABORATÓRIOS FARMACÊUTICOS S.A
- Princípios ativos
- BUDESONIDA;FUMARATO DE FORMOTEROL DI-HIDRATADO
- Embalagem
- 12 MCG + 400 MCG CAP DURA PO INAL CT FR PLAS OPC X 15
- Regime de dispensação
- Tarja Vermelha
- Tipo de produto
- Similar
- Classe terapêutica
- R3F1 - ANTIASMÁTICOS/DPOC AGONISTAS B2 ASSOCIADOS A CORTICOSTERÓIDES, INALANTES
- Prescrição
- Sob prescrição ou restrito
Nomes pelos quais este registro é encontrado
- BRONX 12 MCG + 400 MCG CAP DURA PO INAL CT FR PLAS OPC X 15
- BRONX
- BUDESONIDA
- FUMARATO DE FORMOTEROL DI-HIDRATADO
Dados completos da fonte
{
"name": "BRONX 12 MCG + 400 MCG CAP DURA PO INAL CT FR PLAS OPC X 15",
"holder": "ACHÉ LABORATÓRIOS FARMACÊUTICOS S.A",
"stripe": "Tarja Vermelha",
"barcodes": [
"7896658048760"
],
"confaz87": true,
"currency": "BRL",
"marketed": null,
"ggremCode": "552923050160103",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": false,
"holderTaxId": "60.659.463/0029-92",
"priceRegime": "Regulado",
"productName": "BRONX",
"productType": "Similar",
"hospitalOnly": false,
"presentation": "12 MCG + 400 MCG CAP DURA PO INAL CT FR PLAS OPC X 15",
"sourceStatus": null,
"supplyRegime": "Tarja Vermelha",
"factoryPrices": {
"icms-0": "27.59",
"icms-12": "31.35",
"icms-17": "33.24",
"icms-18": "33.65",
"icms-19": "34.06",
"icms-20": "34.49",
"icms-21": "34.92",
"icms-22": "35.37",
"icms-23": "35.83",
"icms-17.5": "33.44",
"icms-19.5": "34.27",
"icms-20.5": "34.70",
"icms-22.5": "35.60",
"icms-12-alc": "30.98",
"icms-17-alc": "32.84",
"icms-18-alc": "33.24",
"icms-19-alc": "33.65",
"icms-20-alc": "34.07",
"icms-21-alc": "34.50",
"icms-22-alc": "34.95",
"icms-23-alc": "35.40",
"withoutTaxes": "27.26",
"icms-17.5-alc": "33.04",
"icms-19.5-alc": "33.86",
"icms-20.5-alc": "34.29",
"icms-22.5-alc": "35.17"
},
"pisCofinsList": "Positiva",
"substanceText": "BUDESONIDA;FUMARATO DE FORMOTEROL DI-HIDRATADO",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "38.03",
"icms-12": "43.21",
"icms-17": "45.82",
"icms-18": "46.38",
"icms-19": "46.95",
"icms-20": "47.54",
"icms-21": "48.13",
"icms-22": "48.75",
"icms-23": "49.39",
"icms-17.5": "46.09",
"icms-19.5": "47.24",
"icms-20.5": "47.83",
"icms-22.5": "49.07",
"icms-12-alc": "42.83",
"icms-17-alc": "45.40",
"icms-18-alc": "45.95",
"icms-19-alc": "46.52",
"icms-20-alc": "47.10",
"icms-21-alc": "47.69",
"icms-22-alc": "48.32",
"icms-23-alc": "48.94",
"withoutTaxes": "37.68",
"icms-17.5-alc": "45.68",
"icms-19.5-alc": "46.81",
"icms-20.5-alc": "47.40",
"icms-22.5-alc": "48.62"
},
"invalidBarcodes": [],
"activeSubstances": [
"BUDESONIDA",
"FUMARATO DE FORMOTEROL DI-HIDRATADO"
],
"therapeuticClass": "R3F1 - ANTIASMÁTICOS/DPOC AGONISTAS B2 ASSOCIADOS A CORTICOSTERÓIDES, INALANTES",
"commercialisation": {
"year": 2025,
"marketed": false
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1057304980136",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "prescription-or-restricted",
"prescriptionRequired": true,
"therapeuticClassCode": "R3F1",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:552923050160103"